ThyroMetrix, Holomic partnership could boost mobile diagnostics market
Clinical thyroid testing company ThyroMetrix has partnered with photonics-based mobile diagnostics developer Holomic LLC for the Holomic Rapid Diagnostic Reader (HRDR-200) for smartphones, which works in sync with ThyroMetrix's ThyroTest thyroid stimulating hormone (TSH) blood test available in the U.S. and Canada.
Clinical thyroid testing company ThyroMetrix (Williamsburg, VA) has partnered with photonics-based mobile diagnostics developer Holomic LLC (Los Angeles, CA) for the Holomic Rapid Diagnostic Reader (HRDR-200) for smartphones, which works in sync with ThyroMetrix's ThyroTest thyroid stimulating hormone (TSH) blood test available in the U.S. and Canada.
ThyroTest, an FDA-regulated and Clinical Laboratory Improvement Amendments (CLIA)-waived rapid immunoassay test, was developed for in-office thyroid diagnosing using a single drop of blood on a small test card. When coupled with the HRDR-200, the result is an inexpensive, portable TSH mobile diagnostic test that enables immediate diagnosis of thyroid disorders.
A drop of blood on the ThyroTest card inserted into the HRDR-200, which is attached to the existing camera unit of a smartphone, can be imaged under LED-based illumination in a special optical interface. Captured raw images are digitally processed through a smartphone application to reveal test results immediately.
Holomic, LLC is a finalist in the Nokia Sensing XCHALLENGE, a global competition that identifies breakthroughs in health sensing technology. ThyroMetrix is supporting their entry in the competition by providing testing services through their ThyroScore program of which Holomic is a sponsor. Following successful trials and FDA approval, Holomic's innovative technology will be incorporated into the ThyroMetrix Diagnostic System for rapid point-of-care testing.